The application penetration rate of MES in the pharmaceutical industry is much lower than that in discrete manufacturing, food and beverage industries, and the domestic pharmaceutical MES market is almost monopolized by Rockwell, Siemens, Weilong and other foreign products. The market is growing year by year, and the demand for pharmaceutical MES is increasing. There are also domestic MES manufacturers who are attacking the field of pharmaceutical MES. However, the technical barriers of pharmaceutical MES are much higher than other industries. Currently, they are all project-based businesses. Mainly, and has not formed a competitive product, pharmaceutical MES is currently facing a vast blue ocean full of reefs.

The prospect of pharmaceutical MES products is unquestionable. At present, the utilization rate of MES in the domestic pharmaceutical industry is still low. However, with the progress of pharmaceutical technology, the development of production automation, and the adjustment of national regulatory policies, the market of pharmaceutical MES is also expanding year by year. Although At present, the giants of foreign pharmaceutical MES still occupy a large first-mover advantage, but foreign software products have been difficult to implement since they entered the Chinese market. There are many cases of failure after implementation, and the situation of acclimatization has always existed. After MES begins to face small and medium-sized enterprises, the original drawbacks of foreign software products will become more serious. Foreign pharmaceutical MES products have problems such as high system complexity and inconsistent operating habits with domestic ones. When faced with projects that require some flexible adjustments, because there is no support for technical development, if they cannot be realized through existing system configuration or expansion Just wait and die.

The increasing market demand for pharmaceutical MES has brought more and more opportunities to domestic MES manufacturers, and the international situation is also becoming more and more severe. The pharmaceutical industry is a particularly sensitive industry, and the risk of relying on foreign MES systems for a long time will also increase. As a domestic MES manufacturer, we also strive to contribute to the development of domestic pharmaceutical MES products on the basis of our own development. After two years of hard work, Dacheng Pharmaceutical MES has integrated the top domestic implementation design team and years of MES development experience. The technical team of the company has jointly broken the industry and technical barriers and developed a pharmaceutical MES product that is used by me. Although the current domestic pharmaceutical MES is far from the same as the MES in discrete manufacturing and other industries, but in order to seize the opportunity, our Dacheng Pharmaceutical MES has set sail, and we also hope that the majority of domestic pharmaceutical manufacturers can give us opportunities to develop together. .

Hongzhi is willing to use professional technology, first-class quality and perfect service to empower the digital informatization construction of manufacturing enterprises.